
FDA Consumer Health Information
Medication Safety: Advice for New Moms
What to Know When Buying or Using a Breast Pump

May 9, 2017
Spotlight on CDER Science: Modernizing the Way Drugs Are Made: A Transition to Continuous Manufacturing
C.O. Truxton, Inc. Issues Voluntary Nationwide Recall of Amitriptyline HCL Tablets, USP 50mg and Phenobarbital Tablets, USP 15mg, 30mg, 60mg, 100mg Due to Potential Label Mix-Up
Drug Approval Packages
Ocrevus (ocrelizumab) Injection
Drug Firm Annual Registration Status (updated)
Drug Firm Annual Registration Status Download File (updated)
Drug Trials Snapshots: RYDAPT
La FDA aprueba cambios en la etiqueta para el uso de anestésicos generales y sedantes en niños pequeños
National Drug Code Directory
Wholesale Distributor and Third-Party Logistics Providers Reporting(updated)
New and Generic Drug Approvals
May 9, 2017
Drug Name and
Application NumberActive IngredientDosage Form/ RouteSubmissionCompanySubmission ClassificationSubmission StatusBavencio
BLA #761078 Avelumab Injectable; Intravenous ORIG-1 Emd Serono Inc Type 1 - New Molecular Entity Approved
Showing 1 to 1 of 1 entries
May 8, 2017
Drug Name and
Application NumberActive IngredientDosage Form/ RouteSubmissionCompanySubmission ClassificationSubmission StatusArestin
NDA #050781 Minocycline Hydrochloride Powder, Extended Release; Dental SUPPL-20 Orapharma Labeling Approved
Bactroban
NDA #050591 Mupirocin Ointment; Topical SUPPL-34 Glaxosmithkline Labeling Approved
Bactroban
NDA #050703 Mupirocin Calcium Ointment; Nasal SUPPL-17 Glaxosmithkline Labeling Approved
Bactroban
NDA #050746 Mupirocin Calcium Cream; Topical SUPPL-21 Glaxosmithkline Labeling Approved
Epivir-Hbv
NDA #021003 Lamivudine Tablet; Oral SUPPL-16 Glaxosmithkline Labeling Approved
Epivir-Hbv
NDA #021004 Lamivudine Solution; Oral SUPPL-16 Glaxosmithkline Labeling Approved
Indomethacin
ANDA #204853 Indomethacin Capsule, Extended Release; Oral ORIG-1 Novast Labs Ltd Approved
Minolira
NDA #209269 Minocycline Hydrochloride Tablet, Extended Release; Oral ORIG-1 Dr Reddys Labs Ltd Type 5 - New Formulation or New Manufacturer Approved
Norgestrel and Ethinyl Estradiol
ANDA #202875 Ethinyl Estradiol; Norgestrel Tablet; Oral-28 ORIG-1 Mylan Labs Ltd Approved
Novolog Mix 70/30 Flexpen
NDA #021172 Insulin Aspart Protamine Recombinant; Insulin Aspart Recombinant Injectable; Subcutaneous SUPPL-62 Novo Nordisk Inc Labeling Approved
Novolog Mix 70/30
NDA #021172 Insulin Aspart Protamine Recombinant; Insulin Aspart Recombinant Injectable; Subcutaneous SUPPL-62 Novo Nordisk Inc Labeling Approved
Novolog Mix 70/30 Penfill
NDA #021172 Insulin Aspart Protamine Recombinant; Insulin Aspart Recombinant Injectable; Subcutaneous SUPPL-62 Novo Nordisk Inc Labeling Approved
Purixan
NDA #205919 Mercaptopurine Suspension; Oral SUPPL-2 Nova Labs Ltd Labeling Approved
Purixan
NDA #205919 Mercaptopurine Suspension; Oral SUPPL-2 Nova Labs Ltd Labeling Approved
Purixan
NDA #205919 Mercaptopurine Suspension; Oral SUPPL-2 Nova Labs Ltd Labeling Approved
Saizen
NDA #019764 Somatropin Recombinant Injectable; Injection SUPPL-86 Emd Serono Labeling Approved
Saizen
NDA #019764 Somatropin Recombinant Injectable; Injection SUPPL-86 Emd Serono Labeling Approved
Sodium Phenylacetate and Sodium Benzoate
ANDA #208521 Sodium Benzoate; Sodium Phenylacetate Solution; Iv (Infusion) ORIG-1 Maia Pharms Inc